Showing results (1441-1450 of 2,791) with videos related to
Sort By:
Pageof 280
Drugs & Aging|October 6, 2011
Parenteral versus oral administration of systemic antimicrobials in European nursing homes: a point-prevalence surveyElisabeth Broex, Boudewijn Catry, Katrien Latour, et al.Drugs & Aging|October 6, 2011
Determination of digoxin clearance in Japanese elderly patients for optimization of drug therapy: a population pharmacokinetics analysis using nonlinear mixed-effects modellingMiho Yukawa, Eiji Yukawa, Fumihiro Suematsu, et al.Drugs & Aging|December 24, 2011
Spotlight on eldecalcitol in osteoporosisMark Sanford, Paul L McCormackDrugs & Aging|May 30, 2009
Off-label use of bevacizumab for the treatment of age-related macular degeneration: what is the evidence?Focke Ziemssen, Salvatore Grisanti, Karl Ulrich Bartz-Schmidt, et al.Drugs & Aging|May 30, 2009
Polypharmacy among disabled Taiwanese elderly: a longitudinal observational studyDing-Cheng Derrick Chan, Yi-Ting Hao, Shwu-Chong WuDrugs & Aging|July 14, 2009
Management of secondary hyperparathyroidism in the elderly patient with chronic kidney diseaseMario Cozzolino, Maurizio Gallieni, Sabina Pasho, et al.Drugs & Aging|July 14, 2009
Constipation in the elderly: management strategiesGiancarlo Spinzi, Arnaldo Amato, Gianni Imperiali, et al.Drugs & Aging|March 1, 2012
Use of clarithromycin and adverse cardiovascular events among older patients receiving donepezil: a population-based, nested case-control studyJanine R Hutson, Hadas D Fischer, Xuesong Wang, et al.Drugs & Aging|September 24, 2008
Viral hepatitis in elderly haemodialysis patients: current prevention and management strategiesMatthias GirndtDrugs & Aging|September 24, 2008
Acquisition costs and use of Medicare Part D-excluded drugs in Veterans Health Administration long-stay nursing home residents: a national, descriptive, secondary data analysisDustin D French, Robert R Campbell, Laurence Z Rubenstein, et al.Pageof 280